argenx SE

30
Sell
  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: NL0010832176
EUR
792.20
10.8 (1.38%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationCash Flow
argenx SE Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
No of Months
12
12
12
12
12
12
Profit Before Tax
43.00
-303.00
-711.00
-350.00
-540.00
-163.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
-300.00
-285.00
-357.00
-288.00
-13.00
276.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
26.00
-302.00
-808.00
-511.00
-342.00
140.00
Cash Flow from Investing Activities
-766.00
199.00
-451.00
-295.00
295.00
-749.00
Cash Flow from Financing Activities
258.00
1,236.00
802.00
948.00
730.00
659.00
Net Cash Inflow / Outflow
-507.00
1,154.00
-508.00
99.00
740.00
50.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
-26.00
21.00
-51.00
-41.00
57.00
0.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in EUR Million
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of argenx SE
Markets Mojo
Figures in Million
consolidated Cash Flow Results
Markets Mojo
Markets Mojo
Change(EUR)
Change(%)
Profit Before Tax
43.1897931335712
-37.6870000000662
80.00
214.60%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
-300.615493013886
-3.85800000000677
-297.00
-7692.00%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
26.719281671871
-24.1540000000424
50.00
210.62%
Cash Flow from Investing Activities
-766.617441402927
-2.71400000000476
-764.00
-28146.77%
Cash Flow from Financing Activities
258.631220027714
51.3000000000901
207.00
404.15%
Net Cash Inflow / Outflow
-507.453721678203
24.4180000000429
-531.00
-2178.20%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
-26.1867819748606
-0.0140000000000246
-26.00
-186948.44%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'24
stock-summary

YoY Growth in year ended Dec 2024 is 108.82% vs 62.52% in Dec 2023

Dec'24
Dec'23
Change(%)
Cash Flow from Operating Activities
26.72
-303.00
108.82%